NRAS and neoplasm: Of note, the use of MRTX1257 at the concentrations of 5 and 10 nM during 24 h did not provide any radio-sensitizing effect in both CT26 KRASG12C+/+ and LL2 NRAS−/− tumor cells (Additional file 1: Figure S1A, B